Douglas E. Onsi is CFO & Secretary +1 at LEAP THERAPEUTICS, INC. (LPTX). They have made 3 open-market trades across 2 companies since 2017, most recently 2025-12-23.
CIK 0001270185
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $13.9M since 2017, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYPH | 106,858 | $275K |
| LPTX | 106,146 | $218K |
| Total | $492K |
Shares reported on the most recent Form 4, priced at the 2025-12-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.